Insurance distributor SelectQuote's Q4 revenue falls 7%, misses analyst estimates

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell".

The average consensus recommendation for the multiline insurance & brokers peer group is "buy".

Wall Street's median 12-month price target for SelectQuote, Inc. is $3.00, about 286.6% above its August 24 closing price of $0.78.

SelectQuote expects fiscal 2027 revenue between $1.35 bln and $1.45 bln. The company sees fiscal 2027 adjusted EBITDA of $90 mln to $115 mln and forecasts fiscal 2027 operating cash flow of more than $60 mln.

The company said improved operating cash flow was largely driven by scale in Healthcare Services and operating efficiency.

Senior segment revenue and policy submissions declined, reflecting industry turbulence and changes by insurance carriers.

SelectQuote said technology-enabled workstream efficiencies have been implemented and are expected to drive annual expense savings of over $30 mln.

Insurance distributor SelectQuote's fiscal fourth-quarter revenue declined and missed analyst expectations. The company posted a net loss for the quarter, while adjusted EBITDA improved year over year.